Document is current
Any future updates will be listed below
-
Authors
Kautzky, A
James, G M
Philippe, C
Baldinger-Melich, P
Kraus, C
Kranz, G S
Vanicek, T
Gryglewski, G
Wadsak, W
Mitterhauser, M
Rujescu, D
Kasper, S
Lanzenberger, R
- License Information
-
More Information
Article History
Received: 17 December 2016
Revised: 8 April 2017
Accepted: 20 April 2017
First Online: 13 June 2017
Competing interests
: SK received grants/research support, consulting fees and/or honoraria within the last 3 years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe and Servier. RL received travel grants and/or conference speaker honoraria from AstraZeneca, Lundbeck A/S, Dr Willmar Schwabe GmbH, AOP Orphan Pharmaceuticals AG, Janssen-Cilag Pharma GmbH and Roche Austria GmbH. Without any relevance to this work, WW received speaker honoraria from GE Healthcare, research grants from DSD, BSM Diagnostica and ABX and is a part-time employee of CBmed GmbH (Graz, Austria). Without any relevance to this work, MM received speaker honoraria from GE Healthcare. PB-M received a travel grant from AOP Orphan Pharmaceuticals AG and speaker honoraria from Janssen. CK has received travel grants from Roche Austria GmbH and AOP Orphan. GSK received travel grants from Roche and Pfizer. The remaining authors declare no conflict of interest.
